Articles from Quibim

Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the formation of its new Board of Directors. This strategic move aligns with Quibim's commitment to innovation and growth in the healthcare sector. It follows the recent FDA 510(k) clearance of its flagship product, QP-Prostate CAD, and the close of a $50M Series A funding round in January. Quibim’s advanced imaging solutions are currently utilized across more than 180 sites worldwide.

Quibim, a global company pioneering imaging biomarkers for precision medicine, announces that its prostate cancer lesion detection capability of its flagship QP-Prostate® CAD solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance marks a significant milestone in Quibim’s mission to enhance prostate cancer detection and treatment. QP-Prostate, which uses algorithms trained on actual pathology data as ground truth, already holds a CE mark for the European Union, a UKCA mark for the United Kingdom, and approved by the TGA (Australia) meaning it is cleared to be used by clinicians in those markets.

Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing. The company has experienced remarkable growth in the number of patients analyzed by its products over the past year. Driven by several regulatory approvals and global commercial partnerships, patient analysis surged by 168% quarter-on-quarter. The financing was led by Asabys (through its fund Sabadell Asabys II) and Buenavista Equity Partners (through the BHG I fund, created in partnership with Columbus Venture Partners), and joined by UI Investissements, and GoHub Ventures as new investors. It was also joined by current investors, Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures and Leadwind (KFund’s early growth fund), and individual investors, including Tony Fadell, Build Collective Principal, Nest founder and inventor of the iPod, and Dr. Jonathan Milner, founder of Abcam plc.